Skip to main content

Health and Medicine

A “public” target for HIV

Jun. 8, 2018—Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.

Read more


Enzyme protects against obesity-related heart disease

Jun. 7, 2018—Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.

Read more


Student-run clinics may reduce hospital utilization

Jun. 7, 2018—Student-run free health clinics, a hallmark of most medical schools across the country, not only provide valuable clinical experience for the students who volunteer there, but may actually reduce hospital utilization by the patients in their care, according to a Vanderbilt study recently published in the Journal of Health Care for the Poor and Underserved.

Read more


New PET/CT scanner set to expand research opportunities

Jun. 7, 2018—A research-dedicated PET/CT scanner installed recently in the Vanderbilt University Institute of Imaging Science (VUIIS) will expand opportunities for Vanderbilt researchers to conduct studies of a wide range of disorders, from cancer to Alzheimer’s disease.

Read more


VU BreakThru: Leveraging quality improvement efforts to increase HPV vaccination rates in Tennessee

May. 31, 2018—Although HPV vaccination in adolescence can successfully prevent six kinds of cancer, rates in Tennessee remain relatively low, while occurrence of these cancers remains relatively high compared to the rest of the country.  Pamela Hull, assistant professor of medicine, and her colleagues are conducting a study funded by the HPV ACTIVE TIPs award, in collaboration with the Cumberland Pediatric Foundation, to test a model for disseminating a web-based quality improvement coaching program to pediatric clinics.

Read more


Research reveals underappreciated role of brainstem in epilepsy

May. 31, 2018—New research from Vanderbilt suggests that repeated seizures reduce brainstem connectivity, a possible contributor to unexplained neurocognitive problems in epilepsy patients.

Read more


Team seeks to shed light on rare immune-mediated adverse drug reaction

May. 31, 2018—Thirty years ago when she was 16, Katie Niemeyer was prescribed carbamazepine for depression. Three weeks later she was in a St. Louis, Missouri, burn unit with second and third degree burns all over her body. “My parents were told the chances of me surviving were slim,” she said.

Read more


New research finds lung cancer risk drops substantially within five years of quitting smoking

May. 29, 2018—Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer.  That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.

Read more


New method to thwart false positives in CT-lung cancer screening

May. 24, 2018—A team of investigators led by Fabien Maldonado, MD, associate professor of Medicine at Vanderbilt, and Tobias Peikert, MD, assistant professor of Medicine at Mayo Clinic, Rochester, Minnesota, has identified a new technology to address false positives in CT-based lung cancer screening. The study was published in the latest issue of PLOS One.

Read more


Evolution of a deadly virus

May. 23, 2018—Genomic sequences have revealed that Florida is a major source of a mosquito-borne virus that causes disease in horses and humans.

Read more


New target to stop Ebola

May. 21, 2018—A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members.

Read more


Shaping reward circuits

May. 18, 2018—Using techniques to control and monitor the activities of individual neurons, Vanderbilt investigators are probing the brain’s reward circuitry.

Read more


Page 2 of 13812345678...Last »

Upcoming Events

MORE EVENTS »